AC Immune SA
ACIU
$1.68
$0.021.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.96M | -57.22M | -44.59M | -68.10M | -61.66M |
| Total Depreciation and Amortization | 2.50M | 2.46M | 2.48M | 2.49M | 2.49M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.60M | 7.74M | 12.02M | 14.30M | 6.05M |
| Change in Net Operating Assets | 96.09M | 119.36M | 77.39M | 99.89M | 5.25M |
| Cash from Operations | 50.23M | 72.33M | 47.29M | 48.58M | -47.88M |
| Capital Expenditure | -775.80K | -657.90K | -742.90K | -864.50K | -961.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.47M | -116.90M | -86.17M | -78.29M | -85.10K |
| Cash from Investing | -87.24M | -117.56M | -86.91M | -79.15M | -1.05M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -769.00K | -683.00K | -651.00K | -618.00K | -580.00K |
| Issuance of Common Stock | 135.00K | 137.00K | 41.30M | 41.88M | 43.80M |
| Repurchase of Common Stock | -26.00K | -26.00K | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -30.00K | -548.00K | -547.00K | -534.00K | -517.00K |
| Cash from Financing | -779.90K | -1.28M | 45.28M | 45.99M | 48.19M |
| Foreign Exchange rate Adjustments | -4.12M | -1.83M | -5.80M | -2.57M | 219.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.91M | -48.34M | -140.70K | 12.85M | -518.10K |